Diabetes

Latest News


Latest Videos


CME Content


More News

A bill introduced yesterday by Representative Maxine Waters, with support from the American Diabetes Association, would eliminate cost sharing for patients with diabetes requiring insulin amid the coronavirus disease 2019 pandemic; White House officials have decided to not release economic projections this summer for the first time since the 1970s; CDC provides recommendations for employers returning to the workplace.

This week, the top managed care news included lower insulin costs for seniors in certain plans; discussions on the future of the Biologics Price Competition and Innovation Act; takeaways from Sharecare's Flatten the Curve Survey.

Teenagers with obesity, type 2 diabetes (T2D), or high blood pressure may have a higher risk of experiencing premature vascular aging compared with teens without the conditions, according to a study published in the Journal of the American Heart Association.

African Americans with severe sleep apnea are more likely to have higher blood glucose levels, according to a new study published in the Journal of the American Heart Association. High blood glucose levels increase the risk of developing diabetes, a disease already more prevalent in African Americans.

Recently, it has been shown that the mechanism by which glucose is managed can have a substantial impact on cardiovascular outcomes. For this reason, along with increasing prevalence of type 2 diabetes (T2D), effective, patient-centered management of coronary artery disease (CAD) in patients with diabetes is imperative to optimize patient outcomes, the American Heart Association said.

This week, the top managed care news includes a CDC report says diabetes is the condition most linked with coronavirus disease 2019, CMS temporarily suspends rules to give hospitals more capacity during the COVID-19 pandemic, and a late-stage trial for dapagliflozin ends early after showing efficacy for chronic kidney disease.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo